Researchers from the USA found that the experimental treatment method, based on a rare genetic mutation, in the future, can provide protection from any viral epidemics.
according to the statement of Columbia University, researchers have carried out work aimed at studying a genetic mutation that occurs in a small number of people, but has protective properties against Viruses.
researchers tried to imitate in the laboratory conditions the antiviral effects of this mutation that causes a protein deficiency “ISG15”, which plays an immunomodulating role in the human body.
researchers applied the experimental treatment method, developed on the basis of studying the mutation, to the experimental rabbits and mice in the form of nasal drops and observed, which observed, which The antiviral effect observed in people was temporarily manifested in experimental animals.
researchers noted that experimental treatment for a short time prevented the reproduction of viruses causing influenza and pandemia Covid-19, in the body of the experimental animals and reduced the severity of the disease. Against any viruses, it predicts that the technology developed by them can be used to protect against future viral epidemics.
it is noted that some features of the method still require finalization, and it is also unknown how long the antiviral protection is valid, which, according to estimates, is from 3 to 4 days.
The study is published in the journal “Science Translational medicine. “